Condensed Consoliated Statements of Cash Flows [Supplemental] (USD $)	9 Months Ended		123 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
Supplemental disclosure of cash flow information:
Interest paid	$ 882	$ 28,212	$ 68,387
Supplemental disclosure of noncash investing and financing activities:
Issuance of common stock for acquisitions	0	1,491,937	14,881,163
Conversion of debt to common stock and warrants	2,401,071	422,000	2,823,071
In-process research and development acquired	0	17,742,110	17,742,110
Investment in Hedrin JV	0	500,000	1,250,000
Beneficial conversion feature	2,245,596	0	2,245,596
Warrants issued with notes payable	0	0	250,562
Note issued to settle accrued expenses	0	0	211,900
Common stock issued in satisfaction of accounts payable	0	0	770,000
Imputed and accrued preferred stock dividend	0	0	1,179,644
Conversion of preferred stock to common stock	0	0	1,067
Preferred stock dividends paid by issuance of shares	0	0	759,134
Issuance of common stock in connection with in-licensing agreement	0	0	232,500
Marketable equity securities received in connection with sale of license	0	0	359,907
Warrants issued to consultant	0	0	83,670
Net liabilities assumed over assets acquired in business combination	0	0	(675,416)
Cashless exercise of warrants	$ 0	$ 0	$ 33